CAS: 42233-11-4; Hexadecyl Docosanoate

上下游产品

CAS号36653-82-4 十六醇 | CAS号112-85-6 山嵛酸

📜1-十六烷醇,二十二酸置于氯化胆碱,Zinc(II) Chloride体系中,化学反应 12.0H,以95%的收率获得产物二十二烷酸十六烷酯
参考文献:路易斯酸性离子液体氯化胆碱.2Zncl 2的液-液两相合成长链蜡酯
标题:路易斯酸性离子液体氯化胆碱.2Zncl 2的液-液两相合成长链蜡酯
摘要:描述了在路易斯酸性离子液体中胆碱氯化物.2Zncl 2通过长链羧酸与长链醇的酯化进行的蜡酯的第一次液-液双相合成.所报道的反应系统具有均相和非均相催化的优点,具有高的产物收率,并且产物的容易性以及不使用有机溶剂的催化剂分离.所研究的离子液体在溶剂和催化剂方面都起着双重作用,可以循环使用六次,而活性没有任何明显的损失.
DOI:10.1016/j.Tetlet.2007.07.159

专利信息

专利号:US-7825268-B2
优先权日:2003-12-23
标 题:Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
发明人：STUMPE STEFAN; BREVES ROLAND; HUCHEL URSULA; JANSSEN FRANK; HAETZELT ANDRE
权利人:HENKEL AG & CO KGAA
摘要:Compounds of the Formula I, n nwherein A 1 is O or NH; A 2 is O or S; each of R 1 and R 2 is independently hydrogen, a methyl or C 2 -C 8 -saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group; and R 3 is a C 1 -C 18 -saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group wherein, each of R 1 , R 2 and R 3 comprises a heteroatom selected from the group consisting of O and S in the chain and/or is mono- or multiply-substituted by a substituent selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkyl, trifluoromethyl, C 1 -C 6 -alkoxy, C 6 -C 10 -aryl, and C 1 -C 6 -alkyl-C 6 -C 10 -aryl are useful for controlling the interaction process between microorganisms such as in the development and/or maturation of biofilms; multicellular swarm behavior; the concerted development of antibiotic resistances; the concerted synthesis of antibiotics; the concerted synthesis of pigments; the concerted production of extracellular enzymes; or the concerted production of virulence factors.

专利号:EP-1437117-A1
优先权日:2002-12-19
标 题:Use of Sinapic acid and/or its derivatives
发明人：MOUSSOU PHILIPPE; DANOUX LOUIS; JEANMAIRE CHRISTINE; PAULY GILLES
权利人:COGNIS FRANCE SA
摘要:Use of sinapic acid and / or sinapic acid derivatives fornProduction of cosmetic and / or dermopharmaceutical preparationsnto protect against skin aging and wrinkling, especially throughnUV radiation, for the production of cosmetic and / orndermopharmaceutical preparations for delaying the aging ofnMitochondria, to protect the mitochondrial genome from oxidativenStress, to improve the energy production capacity of the humannSkin, the use of sinapic acid and / or sinapic acid derivatives fornProduction of cosmetic and / or dermopharmaceutical preparationsnto protect cellular DNA, to protect against thymine dimer formationnInfluence of UV-B radiation in skin cells and for the improvement ofnDNA repair mechanism in skin cells, to stimulate thenCollagen synthesis, as well as the use for the preparation of preparationsnfor wound healing after non-enzymatic glycosylation or influence ofnoxidative stress or environmental toxins.

专利号:US-2011236330-A1
优先权日:2008-12-09
标 题:Skin Whitening
发明人：MOUSSOU PHILIPPE; SABADOTTO MELANIE; RATHJENS ANDREAS
权利人:MOUSSOU PHILIPPE; SABADOTTO MELANIE; RATHJENS ANDREAS
摘要:Methods for reducing pigmentation or hyperpigmentation of skin comprising applying to the skin a substance of formula (I) in the D-form, L-form or racemic form (D,L) are disclosed: n n n n n n n n n n whereinn R 1 is selected from the group consisting of a hydrogen group (—H), a methyl group (—CH 3 ), an ethyl group (—CH 2 CH 3 ), a C3 alkyl group, a C4 alkyl group, an acetyl group (—C(O)CH 3 ), a propanoyl group (—C(O)CH 2 CH 3 ), an n-butanoyl group (—C(O)CH 2 CH 2 CH 3 ), and a 2-methyl-propanoyl group (—C(O)CH(CH 3 ) 2 ), R 2 is selected from the group consisting of a hydrogen group (—H), an ethyl group (CH 2 CH 3 ), a C3 alkyl group, a C4 alkyl group, an acetyl group (—C(O)CH 3 ), a propanoyl group (—C(O)CH 2 CH 3 ), an n-butanoyl group (—C(O)CH 2 CH 2 CH 3 ), and a 2-methyl-propanoyl group (—C(O)CH(CH 3 ) 2 ), R 3 is selected from the group consisting of a hydroxyl group (—OH), an amino group (NH 2 ), a methoxy group (OCH 3 ), an ethoxy group (—OCH 2 CH 3 ), a C3 alkoxy group, a C4 alkoxy group, and a benzyloxy group (—OCH 2 C 6 H 5 ), and X and Y are independently selected from the group consisting of a hydrogen group (—H), a methyl group (—CH 3 ), an ethyl group (—CH 2 CH 3 ), a C3 group alkyl, a C4 alkyl group, a halogen group, a methoxy group (—OCH 3 ), an ethoxy group (—OCH 2 CH 3 ), a C3 alkoxy group, a C4 alkoxy group, and a benzyloxy group (—OCH 2 C 6 H 5 ), provided that at least one of X and Y is not a hydrogen group (—H). nn Cosmetic compositions and/or topical compositions comprising the substance are useful for (i) lightening of the skin and/or (ii) whitening of the skin and/or (iii) reduction of pigmentation of the skin and/or (iv) reduction of hyperpigmentation of the skin and/or (v) inhibition of melanogenesis in the skin and/or (vi) prevention and/or retardation of signs of ageing and/or improving the skin appearance of an aged skin. Such composition are also useful for treatment of pigmentation or hyperpigmentation of the skin due to abnormal melanin synthesis and/or secretion.